The current work strongly advocates for further probing of the mechanisms of degradation of other immune checkpoint proteins and their therapeutic relevance; as well as for the investigation of a potentially broader role that c-Cbl may play in other conditions driven by immune checkpoint abnormalities such as autoimmune diseases and viral infections. The gene discussed is CBL; the disease is autoimmune disease.